EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies

Leila Tabrizi, Alan M Jones iD, Isolda Romero-Canelon iD, Andrea Erxleben iD

Inorganic Chemistry · 2024

DOI: 10.1021/acs.inorgchem.4c01586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Leila Tabrizi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Chemical Sciences, University of Galway, Galway H91 TK33, Ireland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Antineoplastic Agents, Drug Screening Assays, Antitumor, Apoptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer has the worst case-to-fatality ratio of all gynecologic malignancies. The main reasons for the high mortality rate are relapse and the development of chemoresistance. In this paper, the cytotoxic activity of two new multiaction platinum(IV) derivatives of cisplatin and oxaliplatin in a panel of ovarian cancer cells is reported. Cis,cis,trans-[Pt(NH3)2Cl2(IPA)(DCA)] (1) and trans-[Pt(DACH)(OX)(IPA)(DCA)] (2) (IPA = indole-3-propionic acid, DCA = dichloroacetate, DACH = 1R,2R-1,2-diaminocyclohexane, OX = oxalate) were synthesized and characterized by elemental analysis, ESI-MS, FT-IR, and 1H, 13C, and195Pt NMR spectroscopy. The biological activity was evaluated in A2780, PEA1, PEA2, SKOV3, SW626, and OVCAR3 cells. Both complexes are potent cytotoxins. Remarkably, complex 2 is 14 times more active in OVCAR3 cells than cisplatin and is able to overcome cisplatin resistance in PEA2 and A2780cis cells, which are models of post-treatment patient-developed and laboratory-induced resistance. This complex also shows activity in 3D cancer models of the A2780 cells. Mechanistic studies revealed that the complexes induce apoptosis via DNA damage and ROS generation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAntineoplastic AgentsDrug Screening Assays, AntitumorApoptosisHumansFemaleCoordination ComplexesOrganoplatinum CompoundsReactive Oxygen SpeciesMolecular StructureCell ProliferationCell Line, TumorCell SurvivalCisplatinStructure-Activity RelationshipDose-Response Relationship, Drug

Substanzen

Antineoplastic AgentsCoordination ComplexesOrganoplatinum CompoundsReactive Oxygen SpeciesCisplatin

Autor:innen und Institutionen

  • School of Biological and Chemical Sciences, University of Galway, Galway H91 TK33, Ireland.
  • School of Chemical Sciences, Dublin City University, Dublin D09W6Y4, Ireland.
  • School of Pharmacy, University of Birmingham, Birmingham B15 2TT, U.K.
  • Department of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.
  • Synthesis and Solid State Pharmaceutical Centre (SSPC), Limerick V94 T9PX, Ireland.

ORCID-Profile: Alan M Jones, Isolda Romero-Canelon, Andrea Erxleben

Förderung

  • H2020 Marie Sklodowska-Curie Actions

Zitieren

APA

Tabrizi, L., M Jones, A., Romero-Canelon, I., & Erxleben, A. (2024). Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c01586

Vancouver

Tabrizi L, M Jones A, Romero-Canelon I, Erxleben A. Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.4c01586

BibTeX
@article{Tabrizi2024,
  author = {Tabrizi, Leila and M Jones, Alan and Romero-Canelon, Isolda and Erxleben, Andrea},
  title = {Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies},
  journal = {Inorganic Chemistry},
  year = {2024},
  doi = {10.1021/acs.inorgchem.4c01586}
}
Kostenlos starten →